)
DiaSorin (DIA) investor relations material
DiaSorin Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Year-to-date revenues reached €900 million, up 3% year-over-year, with ex-COVID growth of 7% at constant exchange rates and core business (ex-COVID, constant FX) up 6%.
Adjusted EBITDA for 9M 2025 was €302 million, up 3% year-over-year (+7% at CER), with margin improving to 34%.
Immunodiagnostic strategy focused on expanding US hospital footprint, with 90 new hospitals added and a target of 600 by 2027.
Major commercial agreement signed with Quest Diagnostics for the LIAISON PLEX multiplexing molecular platform.
FDA 510(k) clearance received for Simplexa COVID-19, Flu A/B & RSV Direct test on the LIAISON MDX platform.
Financial highlights
Gross profit for the first nine months totaled €587 million (65% of revenues), up 2% year-over-year.
Adjusted EBIT reached €233 million (26% of revenues), in line with prior year.
Adjusted net income was €174 million (19% of revenues); net profit for 9M 2025 was €137 million, down 3% year-over-year.
Adjusted EBITDA margin for 9M 2025 was 34%; Q3 2025 margin was 32%, impacted by tariff changes and sales mix.
Net financial debt stood at €617 million, stable compared to December 2024.
Free cash flow reached €161 million, offset by €97 million in shareholder withdrawal payments and €63 million in dividends.
Outlook and guidance
Full-year 2025 guidance revised: ex-COVID revenue growth of ~5% at CER, COVID-related revenue at €10 million, and adjusted EBITDA margin at ~33%.
High single-digit top-line growth expected for 2026, with mid- to high-single-digit growth for Immuno and double-digit growth for Molecular in the medium term.
2027 targets reaffirmed: high single- to low double-digit CAGR and 36–37% EBITDA margin.
Capital Market Day planned for Q2 2026 to update mid-term targets.
Next DiaSorin earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage